A director at Landbridge Company LLC sold 53,350 shares at 74.498USD and the significance rating of the trade was 81/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years ...
Moody's Ratings (Moody's) downgraded Beazer Homes USA, Inc.'s (Beazer) corporate family rating (CFR) to B2 from B1, its probability of default rating (PDR) to B2-PD from B1-PD, and the ratings on the company's senior unsecured notes to B2 from B1. We also changed Beazer's Speculative Grade Liquidity...
A director at Advanced Micro Devices Inc sold 3,034 shares at 200.000USD and the significance rating of the trade was 60/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two ye...
A director at Constellium SE sold 80,000 shares at 26.446USD and the significance rating of the trade was 86/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly ...
The AI buildout is accelerating in 2026, and we see it is getting difficult to track what is being deployed, by whom, for what usage, with what financing, and on what underlying business model. As GTC approaches, we address all these questions in a series of one-sliders. Today we look into how frontier labs can absorb rising compute costs in 2027 and beyond. Note: For our latest estimates, please see updates to the slides published earlier this week; we are refining our numbers in real time as...
The AI buildout is accelerating in 2026, and we see it is getting difficult to track what is being deployed, by whom, for what usage, with what financing, and on what underlying business model. As GTC approaches, we address all these questions in a series of one-sliders. Today we look into how Hyperscaler P&Ls can absorb 2026 capex, and extend the perspective into the end of the decade. Note: For our latest estimates, please see updates to the slides published earlier this week; we are refinin...
Day One Biopharmaceuticals, Inc. (DAWN - $12.87) and Jazz Pharmaceuticals PLC (JAZZ - $188.69)Shares Jump on News Speculation of Potential Acquisition.Yesterday, DAWN shares jumped as much as +30% after a Betaville "Uncooked Alert" was published stating that the company could be acquired by JAZZ. R
The AI buildout is accelerating in 2026, and we see it is getting difficult to track what is being deployed, by whom, for what usage, with what financing, and on what underlying business model. As GTC approaches, we will try to address all these questions in a series of one-sliders. We follow-up today with the third analysis. Note: For our latest estimates, please see updates to the slides published earlier this week; we are refining our numbers in real time as we progress in this work.
Speaker Bio: John Newman is currently the Herff Chair of Excellence at the University of Memphis School of Law, where he researches and teaches antitrust and unfair competition law. He has previously served in both federal antitrust agencies, first as an Honors Program Trial Attorney with the U.S.
In this report, we establish an initial framework to assess exposure to AI-enabled risk across our coverage group. Specifically, we evaluate the risk of replacement, disintermediation, or both. Our framework measures structural defensibility and business model differentiation against the difficulty
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.